Cargando…
Pathogenesis and Treatment Strategies of COVID-19-Related Hypercoagulant and Thrombotic Complications
The new type of pneumonia caused by the severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) is endemic worldwide, and many countries cannot be spared, becoming a global health concern. The disease was named COVID-19 by the World Health Organization (WHO) on January 30, 2020, when the WHO de...
Autor principal: | Haimei, MA |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7391437/ https://www.ncbi.nlm.nih.gov/pubmed/32722927 http://dx.doi.org/10.1177/1076029620944497 |
Ejemplares similares
-
Management and Perspective of Coronavirus Disease 2019 (COVID-19), Pregnancy, and Hypercoagulability
por: Nasir, Umair, et al.
Publicado: (2021) -
Incidence of thrombotic complications in hospitalised and non‐hospitalised patients after COVID‐19 diagnosis
por: Tholin, Birgitte, et al.
Publicado: (2021) -
Clinical Outcomes of Pulmonary Embolism in Mexican Patients With COVID-19
por: Bobadilla-Rosado, Luis O., et al.
Publicado: (2021) -
Deep Venous Thrombosis in COVID-19 Patients: A Cohort
Analysis
por: Cai, Chuanqi, et al.
Publicado: (2020) -
COVID-19 May Predispose to Thrombosis by Affecting Both Vascular Endothelium and Platelets
por: Cure, Erkan, et al.
Publicado: (2020)